Track topics on Twitter Track topics that are important to you
Carboplatin Cisplatin Decortication Intensity Modulated Radiation Therapy Pemetrexed PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Carboplatin Cisplatin Decortication Intensity Modulated Radiation Therapy Pemetrexed articles that have been published worldwide.
We have published hundreds of Carboplatin Cisplatin Decortication Intensity Modulated Radiation Therapy Pemetrexed news stories on BioPortfolio along with dozens of Carboplatin Cisplatin Decortication Intensity Modulated Radiation Therapy Pemetrexed Clinical Trials and PubMed Articles about Carboplatin Cisplatin Decortication Intensity Modulated Radiation Therapy Pemetrexed for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Carboplatin Cisplatin Decortication Intensity Modulated Radiation Therapy Pemetrexed Companies in our database. You can also find out about relevant Carboplatin Cisplatin Decortication Intensity Modulated Radiation Therapy Pemetrexed Drugs and Medications on this site too.
To assess late toxicity, quality of life and oncological outcome after consolidative whole abdominal radiotherapy (WART) following cytoreductive surgery and carboplatin/paclitaxel chemotherapy in high risk patients with advanced ovarian cancer FIGO stage III using IMRT (Intensity modulated radiation therapy).
Intensity-modulated radiation therapy (IMRT) yields better outcomes and fewer toxicities for radiation therapy (RT) of head and neck cancers (HNCs), including nasopharyngeal cancer (NPC). IMRT is the standard RT treatment and has been widely adopted in Western countries to treat HNCs. However, its uptake in clinical practice among NPC patients has never been studied.
This study recruited two centers with expertise in treating pediatric brain tumors with robotic radiation delivery system photon therapy and proton therapy, respectively, to study the plan quality and the dose deposition characteristics of robotic radiation delivery system photon and intensity modulated proton therapy (IMPT) plans.
Increasing radiation dose to the heart is associated with worse survival in stage 3 non-small cell lung cancer (NSCLC). We sought to evaluate the abilities of optimized volumetric modulated arc therapy (VMAT) and intensity-modulated proton therapy (IMPT) to spare cardiac substructures, and sought to determine how a cardiac optimization treatment planning algorithm influences dose distribution to other thoracic organs at risk (OARs).
The purpose of this study was to evaluate the efficacy and tolerance of normofractionated stereotactic radiation therapy (RT) and intensity modulated RT with helical tomotherapy for skull base meningioma.
The present study examined the efficacy and complications associated with intensity-modulated radiation therapy (IMRT) for optic nerve sheath meningioma (ONSM) in 15 cases and compared visual function before and after treatment.
At present, the management of nasopharyngeal carcinoma (NPC) is mainly based on radiotherapy, but there are many radiation delivery techniques such as intensity-modulated radiotherapy (IMRT) and 2-dimensional radiotherapy (2D-RT).
In this study, we used the concept of organ-equivalent dose (OED) to evaluate the excess absolute risk (EAR) for secondary cancer in various organs after radiation treatment for breast cancer.
To assess the long-term outcomes of patients with squamous cell carcinoma of the anal canal (SCCAC) treated with Intensity-Modulated Radiation Therapy (IMRT).
To view and evaluate the prognosis factors in patients with nasopharyngeal carcinoma (NPC) treated with intensity modulated radiation therapy using nomogram and decision curve analysis (DCA).
In 2013, the American Society for Radiation Oncology recommended against the routine use of intensity-modulated radiation therapy (IMRT) in breast cancer patients. We evaluated trends in the use of IMRT before and after the release of the recommendation. Using SEER-Medicare data, we identified 13,457 breast cancer patients diagnosed between 2012 and 2015 who received breast conserving surgery and post-surgery, whole breast, IMRT or three dimensional conformal radiotherapy. We find that the use of IMRT decre...
Standard first-line therapy for -mutant advanced non-small-cell lung cancer (NSCLC) is an epidermal growth factor receptor (EGFR)-directed oral tyrosine kinase inhibitor. Adding pemetrexed and carboplatin chemotherapy to an oral tyrosine kinase inhibitor may improve outcomes.
For definitive chemoradiotherapy (chemoRT) of head and neck squamous cell carcinoma (HNSCC), cisplatin is the preferred concurrent agent, with superiority over cetuximab for HPV-associated oropharyngeal squamous carcinoma recently shown in 2 randomized trials (RTOG 1016 and De-ESCALaTE). Patients who are not candidates for cisplatin may be treated with carboplatin instead, but its comparative efficacy is unclear. We analyzed nationwide patterns of care and cancer-specific outcomes after cisplatin- versus ca...
Esophageal cancer is a lethal disease of global scope. Radiotherapy is the main method to treat esophageal cancer; however, it concurrently leads to malnutrition. Intensity-modulated radiotherapy (IMRT) is superior to three-dimensional conformal radiation therapy (3D-CRT) in dosimetry and clinical outcomes. In this cohort study, we aimed to compare the effect of 3D-CRT and IMRT on malnutrition status.
In 2013, the American Society for Radiation Oncology (ASTRO) issued a Choosing Wisely recommendation against the routine use of intensity modulated radiotherapy (IMRT) for whole breast irradiation. We evaluated IMRT use and subsequent impact on Medicare expenditure in the period immediately preceding this recommendation to provide a baseline measure of IMRT use and associated cost consequences.
To study the feasibility and the effectiveness of a novel implementation of robust optimization on two sets of CT data simultaneously for skin flashing in intensity-modulated radiation therapy for breast cancer.
Palliative radiation is an effective form of treatment that can provide meaningful symptom relief in a variety of clinical settings. With continuing advances in clinical therapies, long-term survival after palliative treatment for symptomatic disease is increasingly common, and patients may receive a variety of systemic therapy options following radiation. Here, we report a case and management of radiation recall myositis following administration of carboplatin and docetaxel, a combination which has not pre...
Radiation oncologists and radiologists have a unique and mutually dependent relationship. Radiation oncologists rely on diagnostic imaging to locate the tumor and define the treatment target volume, evaluation of response to therapy, and follow-up. Accurate interpretation of post-treatment imaging requires diagnostic radiologists to have a basic understanding of radiation treatment planning and delivery. There are various radiation treatment modalities such as 3D conformal radiation therapy, intensity modul...
Deep inspiration breath hold intensity modulated radiation therapy in A large clinical series of 239 left sided breast cancer patients: A dosimetric analysis of organs at risk doses and clinical feasibility from a single center experience.
To evaluate dose to organs at risk, target coverage and treatment compliance in left sided breast cancer patients (LSBCP) treated with deep inspiration breath hold (DIBH) and intensity modulated radiation therapy (IMRT) technique in a contest of daily clinical practice.
In this study, we developed a gated recurrent unit (GRU)-based recurrent neural network (RNN) for dose-volume histogram (DVH) prediction in volumetric modulated arc therapy (VMAT) planning for nasopharyngeal carcinomas (NPCs) based on uniform-intensity radiation with equal angle intervals and investigated the feasibility and usefulness of this method in optimization.
To investigate the role of intensity-modulated proton therapy (IMPT) for regional nodal irradiation in patients with breast carcinoma in comparison with volumetric-modulated arc therapy (VMAT).
There is a debate about the effectiveness and toxicity of pelvic lymph node (PLN) irradiation for the treatment of men with high-risk prostate cancer. This study compared the toxicity of intensity-modulated radiation therapy (IMRT) to the prostate and the pelvic lymph nodes (PPLN-IMRT) with prostate-only IMRT (PO-IMRT).
Older patients undergoing radiation therapy (RT) for pelvic malignancies are at increased risk for pelvic fracture, which is associated with significant morbidity and mortality. RT techniques such as brachytherapy or intensity modulated RT (IMRT) allow for more conformal dose distributions, but it is not known whether the risk for pelvic fracture varies by RT modality.
To compare and contrast the American Society for Radiation Oncology (ASTRO) Model Policies (MPs) for intensity-modulated radiation therapy (IMRT), stereotactic radiosurgery (SRS), stereotactic ablative radiotherapy (SABR), and proton beam therapy (PBT) with the coverage policies constructed by five of the largest publicly-available commercial insurers throughout the United States (Aetna, Anthem, Cigna, Humana, United).
To evaluate the evolution of radiation-induced brainstem injury (BSI) in nasopharyngeal-carcinoma (NPC) patients treated with intensity-modulated radiotherapy (IMRT) and to identify the critical dosimetric predictors of BSI.